Lymphopoiesis Prebcr-Dependent Events During B Phosphorylation
Total Page:16
File Type:pdf, Size:1020Kb
Heparan Sulfate and Heparin Enhance ERK Phosphorylation and Mediate preBCR-Dependent Events during B Lymphopoiesis This information is current as of September 29, 2021. Craig D. Milne, Steven A. Corfe and Christopher J. Paige J Immunol 2008; 180:2839-2847; ; doi: 10.4049/jimmunol.180.5.2839 http://www.jimmunol.org/content/180/5/2839 Downloaded from References This article cites 30 articles, 16 of which you can access for free at: http://www.jimmunol.org/content/180/5/2839.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 29, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Heparan Sulfate and Heparin Enhance ERK Phosphorylation and Mediate preBCR-Dependent Events during B Lymphopoiesis1 Craig D. Milne,2 Steven A. Corfe, and Christopher J. Paige As B lineage cells develop, they interact with cells, proteins, and extracellular matrix components of the surrounding microen- vironment. In vitro, one critical checkpoint for developing cells occurs as they lose responsiveness to IL-7. These cells require contact with either stromal cells or other B lineage cells to mature. Our results demonstrate that heparan sulfate and heparin are able to promote this transition when added exogenously to the culture system or when heparan sulfate-bearing cell lines are cocultured with primary B cell progenitors. Addition of heparan sulfate or heparin to LPS-stimulated cultures of primary B cell progenitors resulted in more IgM secreted compared with untreated cultures. Heparan sulfate has been Downloaded from reported to be a ligand for the pre-B cell receptor (preBCR). Extending this observation, we found that treatment of ,preBCR؉ cells with heparan sulfate before anti- stimulation leads to increased phosphorylation of ERK1/2. Consequently -preBCR؉ cells proliferate more in the presence of IL-7 and heparan sulfate, whereas preBCR؊ cells are unaffected, sug gesting that in these experiments, heparan sulfate is not directly affecting IL-7 activity. Heparin treatment of cultures induces .many of the same biological effects as treatment with heparan sulfate, including elevated pERK levels in preBCR؉ cells However, heparin reduces the proliferation of cells expressing only the preBCR (opposed to both the preBCR and BCR) http://www.jimmunol.org/ possibly due to internalization of the preBCR. Heparan sulfates are present on stromal cells and B lineage cells present in hemopoietic tissues and may provide stimulation to preB cells testing the signaling capacity of the preBCR. The Journal of Immunology, 2008, 180: 2839–2847. he development of B lineage cells depends on the inte- port of this, Ja¨ck and colleagues (10, 11) developed a soluble gration of signals from several biochemical pathways. preBCR-like molecule and found that it could bind to an uniden- Prominent among these are pathways linked to the pre-B tified 90–135 kDa protein in stromal cell lysates. This interaction T 3 cell receptor (preBCR) and the IL-7R, however, contributions requires the unique tail of 5, which interacts with heparan sulfate from accessory molecules such as CD19, CD22, CD45, and others chains associated with this protein. by guest on September 29, 2021 can alter the signaling milieu and influence the development of B We have previously described a culture system that allows for lineage cells (1, 2). The central importance of the preBCR has been the maturation of B cell progenitors from lineage uncommitted recognized for many years and is most easily demonstrated in ex- cells through to the IgM-secreting mature B cell stage (12–14). perimental systems that are either deficient in one or more com- Consequently, this culture system supports any required signaling ponents of the preBCR or in systems that artificially mimic pre- by the preBCR or other receptors necessary to mediate this mat- BCR-dependent signaling (3–5). uration. Ig-secreting B lineage cells can be generated in vitro from Despite these observations, the precise mechanism by which the ϩ B220 bone marrow progenitors by culturing cells under a series preBCR influences B cell development remains elusive and a num- of different conditions. Early phases require IL-7 for proliferation, ber of models have been proposed (6–8). At one extreme, it is survival, and maturation of progenitor cells; however, to reach the thought that simple assembly of preBCR components is sufficient Ig-secreting stage in vitro, cells must be transferred to cultures to generate critical signals that promote development. Others pos- containing LPS. This transition phase is not well understood, but tulate that receptor engagement is needed to initiate signal trans- duction and a number of ligands have been proposed (9). In sup- has classically required a coculture period between stromal cells and B lineage progenitors (15). This coculture permits B lineage cells to mature to the LPS-responsive stage and, ultimately, secrete Ig. In the absence of this contact-dependent stage, cells do not Ontario Cancer Institute, University Health Network, Department of Immunology, University of Toronto, Toronto, Ontario, Canada respond to LPS and do not secrete Ig. Stromal cells produce many Received for publication August 15, 2007. Accepted for publication December cytokines, growth factors, and adhesion molecules, but it is unclear 17, 2007. which specific molecules are necessary to mediate the maturation The costs of publication of this article were defrayed in part by the payment of page of B lineage cells at this stage. charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. One model suggests that an important stimulus for develop- 1 ing B lineage cells is the loss of IL-7 availability. This has been This work was supported by grants from the Terry Fox Foundation, the National ϩ Cancer Institute of Canada, and the Canadian Institute of Health Research. reported to induce maturation of pre-B cells to the sIgM stage; 2 Address correspondence and reprint requests to Dr. Craig Milne, Ontario Cancer however, we have previously shown this not to be true (16). The Institute, 8-105 Princess Margaret Hospital, Toronto, Ontario, Canada M5G 2M9. loss of IL-7 does not change the number of cells reaching the E-mail address: [email protected] sIgMϩ stage; it merely changes the proportion of cells surviving in 3 Abbreviations used in this paper: preBCR, pre-B cell receptor. culture, to favor more sIgMϩ cells at the expense of sIgMϪ pro-B Copyright © 2008 by The American Association of Immunologists, Inc. 0022-1767/08/$2.00 and pre-B cells. Although possibly acting upon similar cells, the www.jimmunol.org 2840 HEPARAN SULFATE AND HEPARIN MEDIATE preBCR-DEPENDENT EVENTS contact-dependent interactions necessary to mediate the matura- Heparitinase digestion tion of progenitors to the LPS-responsive stage are measured by Ig Cells were treated with heparitinase (from flavobacterium heparinum; secretion, the productive result of LPS-stimulation. These experi- Seikagaku/Associates of Cape Cod catalog no. 100703) at 0.1mU/ml/106 ments do not require IL-7, nor are they hindered by its presence. cells at 37°C for 60 min. Subsequently, cells were washed one time and Previous experiments (15) demonstrated that stromal cells could cultured in the presence of 0.02 mU heparitinase. An additional 0.02mU be replaced at this transition if IL-7-expanded B lineage cells were heparitinase was added every 24 h for the first 3 days of culture. This treatment was sufficient to reduce the epitope detected by the mAb cultured in conditions that promoted cell-cell contact (homotypic clone 10E4. interactions). Progenitors cultured in either condition become re- sponsive to LPS, which subsequently promotes further develop- FACS analysis ment and activation of the cells to secrete IgM. Although much of Cells were washed in FACS buffer (PBS, 3% FCS, and 0.01% sodium the current literature focuses on the interface between stromal cells azide) and resuspended in 96-well, round-bottom assay plates at 104-105 and preB cells, there is less known about potential mediators that cells in 15 l. Labeling was done at 4°C for 15 min in a total volume of 65 l containing optimized dilutions of the following Abs (clone): IgM promote development in the absence of stromal cells, such as in (33.60; made in-house), B220 (RA3-6B2; made in-house), CD2 (RM2-5; our system. For example, we have found that the addition of anti- BD Biosciences), CD19 (MB19-1; eBioscience), CD43 (S7-5; BD Bio- Fab to these cultures prevented maturation (15). We could not sciences), CD117/c-kit (2B8; eBioscience), Ig (187.1; BD Biosciences or detect signaling events initiated within the B cell progenitors ex- polyclonal goat anti-Ig; Southern Biotechnology), CD23 (clone B3B4; posed to the anti- Fab and hypothesized that this reagent may BD Biosciences), IgD (10.4; made in-house), CD86 (M5/114; BD Bio- sciences), CD21 (7G6; BD Biosciences), CD22 (Cy34.1; BD Biosciences), block the interaction between the preBCR and an external ligand, BP1 (6C3; BD Biosciences), 5 (FS1; made in-house), HSA (M1/69; BD or it may disrupt the formation of oligomeric complexes of the Biosciences), CD5 (53-7; BD Biosciences), Mac1 (BD Biosciences), Downloaded from preBCR.